TRANSGENE Says Experimental Cancer Drug Has ‘Enormous Potential’

Bloomberg -- Transgene SA (TNG), a French biotechnology company, is “very confident” about the prospects of an experimental cancer treatment now in clinical testing, Chief Executive Officer Philippe Archinard said.